OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study
Maria Laura Ricardo-Silgado, Sneha Singh, Lizeth Cifuentes, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Milica Radosavljević, Dubravka Švob Štrac, Jasna Jančić, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 23

Pharmacological Treatments and Natural Biocompounds in Weight Management
Amin Gasmi, Pavan Kumar Mujawdiya, Amine Nehaoua, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 212-212
Open Access | Times Cited: 12

Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access

Modern views on therapy with antidepressants on the background of their individual pharmacogenetics
О. А. Yakovleva, S. І. Semenenko, N Shcherbeniuk, et al.
Reports of Vinnytsia National Medical University (2025) Vol. 29, Iss. 1, pp. 168-172
Open Access

Selected Genetic Polymorphisms in Psychiatry
Aneta Bednářová, Dominika Jarčušková, Ivan Dóci, et al.
(2025), pp. 1-28
Closed Access

Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions
M. I. Kuzin, Ekkehard Haen, Nazar Kuzo, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 2, pp. 246-251
Open Access | Times Cited: 2

Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
N. А. Shnayder, V. V. Grechkina, V. V. Arkhipov, et al.
Safety and Risk of Pharmacotherapy (2024) Vol. 12, Iss. 2, pp. 132-154
Open Access | Times Cited: 1

Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study
Farhana Islam, Amanda Lisoway, Edward Oh, et al.
Pharmacopsychiatry (2024) Vol. 57, Iss. 05, pp. 232-244
Closed Access

Selected Genetic Polymorphisms in Psychiatry
Aneta Bednářová, Ivan Dóci, Slávka Dubinská, et al.
(2024), pp. 1-28
Closed Access

CONTROL OF THE PHARMACOGENETICS OF ENZYMES’ MEDICINE BIOTRANSFORMATION – A TOOL FOR PROVIDING PERSONALIZED MEDICINE
О. А. Yakovleva, А. О. Жамба, O Hoina-Kardasevich, et al.
Bulletin of Problems Biology and Medicine (2023) Vol. 1, Iss. 2, pp. 121-121
Open Access

Page 1

Scroll to top